ArticleBMC cardiovascular disorders2025
Construction and validation of a predictive model for intracardiac thrombus risk in patients with dilated cardiomyopathy: a retrospective study.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSystemic embolic events due to exfoliation of intracardiac thrombus (ICT) are one of the catastrophic complications of dilated cardiomyopathy (DCM). This study intended to develop a prediction model to predict the risk of ICT in patients with DCM.
methodsData from 632 patients with DCM from a hospital was collected. ICT was identified based on the results of transthoracic echocardiography. Basic information, vital signs, comorbidities, and biochemical data were measured and collected from each patient. The least absolute shrinkage and selection operator (LASSO) regression was used for the final model variable screening. Four classifiers including Logistic Regression, support vector machine (SVM), Random Forest, and eXtreme Gradient Boosting (XGBoost) were used for model construction respectively. The area under of the curve (AUC) with 95% confidence interval (CI), sensitivity, specificity, and accuracy of the models were calculated to assess the predictive ability of the models.
resultsOf these 632 DCM patients, 88 (13.92%) had ICT and 544 (86.08%) did not. Eleven clinical variables were selected for the construction of predictive models. The AUC of the Logistic Regression model to predict ICT probability was 0.854 (95%CI: 0.811-0.896), the SVM model was 0.769 (95%CI: 0.715-0.824), the Random Forest model was 0.917 (95%CI: 0.887-0.947), and the XGBoost model was 0.947 (95%CI: 0.924-0.969). The Delong test demonstrated that the XGBoost model had the highest AUC for predicting the ICT probability compared to other models (P < 0.05). Moreover, D-dimer, age, and atrial fibrillation contributed the most to the XGBoost model among these 11 variables.
conclusionThe XGBoost model has a good predictive ability in predicting ICT risk in patients with DCM and may assist clinicians in identifying ICT risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.